These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21503766)

  • 21. mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
    Riehle KJ; Yeh MM; Yu JJ; Kenerson HL; Harris WP; Park JO; Yeung RS
    Mod Pathol; 2015 Jan; 28(1):103-10. PubMed ID: 24925055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of claudin-1 and claudin-7 in liver cirrhosis and hepatocellular carcinoma.
    Holczbauer Á; Gyöngyösi B; Lotz G; Törzsök P; Kaposi-Novák P; Szijártó A; Tátrai P; Kupcsulik P; Schaff Z; Kiss A
    Pathol Oncol Res; 2014 Jul; 20(3):493-502. PubMed ID: 24696415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
    Graham RP; Terracciano LM; Meves A; Vanderboom PM; Dasari S; Yeh MM; Torbenson MS; Cruise MW
    Mod Pathol; 2016 Jun; 29(6):607-15. PubMed ID: 27015136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In tight junctions, claudins regulate the interactions between occludin, tricellulin and marvelD3, which, inversely, modulate claudin oligomerization.
    Cording J; Berg J; Käding N; Bellmann C; Tscheik C; Westphal JK; Milatz S; Günzel D; Wolburg H; Piontek J; Huber O; Blasig IE
    J Cell Sci; 2013 Jan; 126(Pt 2):554-64. PubMed ID: 23203797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High mobility group AT-hook 2 is overexpressed in hepatoblastoma.
    Lee CT; Zhang L; Mounajjed T; Wu TT
    Hum Pathol; 2013 May; 44(5):802-10. PubMed ID: 23134771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNAJB1-PRKACA is specific for fibrolamellar carcinoma.
    Graham RP; Jin L; Knutson DL; Kloft-Nelson SM; Greipp PT; Waldburger N; Roessler S; Longerich T; Roberts LR; Oliveira AM; Halling KC; Schirmacher P; Torbenson MS
    Mod Pathol; 2015 Jun; 28(6):822-9. PubMed ID: 25698061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas.
    Holczbauer Á; Gyöngyösi B; Lotz G; Szijártó A; Kupcsulik P; Schaff Z; Kiss A
    J Histochem Cytochem; 2013 Apr; 61(4):294-305. PubMed ID: 23385421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma?
    Malvi D; de Biase D; Fittipaldi S; Grillini M; Visani M; Pession A; D'Errico A; Vasuri F
    Histopathology; 2020 Jan; 76(2):265-274. PubMed ID: 31374137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma.
    Wilczek E; Szparecki G; Lukasik D; Koperski L; Winiarska M; Wilczynski GM; Wasiutynski A; Gornicka B
    PLoS One; 2012; 7(1):e30944. PubMed ID: 22292081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
    Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
    Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas.
    Gerhard R; Ricardo S; Albergaria A; Gomes M; Silva AR; Logullo ÂF; Cameselle-Teijeiro JF; Paredes J; Schmitt F
    Breast; 2012 Jun; 21(3):354-60. PubMed ID: 22464177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
    Goodman ZD; Ishak KG; Langloss JM; Sesterhenn IA; Rabin L
    Cancer; 1985 Jan; 55(1):124-35. PubMed ID: 2578078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type].
    Klimpfinger M; Jatzko G; Trink A; Samec HJ; Gaugg A
    Wien Klin Wochenschr; 1987 Jul; 99(14):505-9. PubMed ID: 2820156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization.
    Kakar S; Chen X; Ho C; Burgart LJ; Sahai V; Dachrut S; Yabes A; Jain D; Ferrell LD
    Mod Pathol; 2009 Jan; 22(1):134-41. PubMed ID: 18997738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant].
    Zermani R; Charfi L; Kourda N; Farah F; Rammeh S; Trabelsi O; Zaouch A; Ben Jilani S
    Tunis Med; 2005 Jul; 83(7):419-21. PubMed ID: 16220700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
    Kaemmerer D; Schindler R; Mußbach F; Dahmen U; Altendorf-Hofmann A; Dirsch O; Sänger J; Schulz S; Lupp A
    BMC Cancer; 2017 Dec; 17(1):896. PubMed ID: 29282035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas.
    Vivekanandan P; Torbenson M
    Mod Pathol; 2008 Jun; 21(6):670-5. PubMed ID: 18264082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: assessment of malignant potential with claudin-10 immunohistochemistry.
    Sanada Y; Yoshida K; Itoh H
    Oncol Rep; 2007 May; 17(5):1177-82. PubMed ID: 17390062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of hepatocellular and cholangiocellular carcinoma in different hepatic lobes.
    Ito Y; Fujioka H; Matsuzaki S; Yamamoto O; Okudaira S; Azuma T; Furui J; Kanematsu T
    Hepatogastroenterology; 2003; 50(49):65-8. PubMed ID: 12629992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings.
    Graham RP; Torbenson MS
    Semin Diagn Pathol; 2017 Mar; 34(2):146-152. PubMed ID: 28110996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.